Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]

Genor Biopharma Holdings Ltd operates as a biopharmaceutical company. The Company focuses on developing and commercializing oncology and autoimmune drugs. Genor Biopharma Holdings serves customers worldwide.

Annual Results Announcement For The Year Ended 31 December 2024

Announcements and Notices - [Very Substantial Acquisition / Issue of Shares under a Specific Mandate / Consideration Issue / Reverse Takeover / Announcement by Offeree Company under the Takeovers Code / Connected Transaction / Change of Company Name / Capital Reorganisation / Share Scheme]

Monthly Update On (1) Very Substantial Acquisition Involving Issue Of Consideration Shares Under Specific Mandate; (2) Reverse Takeover Involving The New Listing Application; (3) Application For Whitewash Waiver; (4) Special Deal; (5) Proposed Change Of Company Name; (6) Proposed Increase In Authorised Share Capital Of The Company; And (7) Proposed Adoption Of The One-Off Share Option Plan

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [Very Substantial Acquisition / Issue of Shares under a Specific Mandate / Consideration Issue / Reverse Takeover / Announcement by Offeree Company under the Takeovers Code / Connected Transaction / Change of Company Name / Capital Reorganisation / Share Scheme / Delay in Dispatch of Circular or other Document]

Monthly Update On (1) Very Substantial Acquisition Involving Issue Of Consideration Shares Under Specific Mandate; (2) Reverse Takeover Involving The New Listing Application; (3) Application For Whitewash Waiver; (4) Special Deal; (5) Proposed Change Of Company Name; (6) Proposed Increase In Authorised Share Capital Of The Company; And (7) Proposed Adoption Of The One-Off Share Option Plan; And Delay In Despatch Of Circular

Announcements and Notices - [Results of EGM/SGM]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genor Biopharma Holdings (6998 HK)

Annual Results Announcement For The Year Ended 31 December 2024

Date Of Board Meeting

Poll Results Of The Extraordinary General Meeting Held On 19 February 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)